Grippferon is a drug for intranasal use that has antiviral, immunomodulatory and anti-inflammatory effects.
Release form and composition
Make drops nasal Grippferon, in plastic bottles of 5 and 10 ml with a dropper cap. 1 ml of drops contains 10,000 IU of recombinant human interferon alpha-2.
Also released spray nasal Grippferon, in bottles of 10 ml (200 doses). 1 ml spray contains 10,000 IU of recombinant human interferon alpha-2.
Indications for use
According to the instructions, Grippferon is prescribed for the treatment of acute acute respiratory viral infections and flu-like conditions.
For the purpose of prevention, it is advisable to use Grippferon during an epidemic of influenza and ARVI.
According to the instructions, Grippferon is contraindicated for use in the following cases:
- Individual intolerance to the active or auxiliary components of the drug;
- Severe allergic diseases.
Dosing and Administration
Drops and spray Grippferon prescribed in the following doses:
- Children under 1 year old - 500 IU (1 drop or 1 injection) up to 5 times per day;
- Children 1-3 years old - 1000 IU (2 drops or 2 injections) 3-4 times a day;
- Children 3-14 years old - 1000 IU or (2 drops or 2 injections) 4-5 times a day;
- Adults - 1500 IU (3 drops or 3 injections) up to 6 times per day.
The duration of the course of use of Grippferon is determined by the attending physician individually, depending on the severity of the disease and the effectiveness of therapy. After instillation of the nose, it is recommended to gently massage the wings of the nose so that the drug is better distributed on the mucous membrane. On average, the duration of the application of drops and spray Grippferon does not exceed 6 days.
In order to prevent after contact with patients or hypothermia, you should apply a standard dose of the drug 2 times within 1 day. For seasonal epidemics, a standard dose of Grippferon should be taken once every 1-2 days (preferably in the morning or immediately before leaving the house). If necessary, the course of therapy with Grippferon is repeated.
Before the first application of the spray, it is necessary to press the sprayer button several times in order to achieve the correct dosing. The nozzle nebulizer gently injected into the nasal passages and press the spray button all the way.
The use of Grippferon as a whole is positively tolerated by patients and does not cause side effects. Some patients noted the development of allergic reactions due to hypersensitivity to the active or auxiliary components of the drug.
The use of the drug is allowed for the prevention and treatment of SARS and influenza in pregnant women and breast-feeding a child.
Do not prescribe Grippferon concurrently with other drugs for intranasal use, which have a vasoconstrictor effect.
Data overdose Grippferon not been reported.
During therapy with Grippferon, it is possible to control potentially dangerous mechanisms that require increased concentration of attention.
Analogues of the drug are Nazoferon, Interferon, Reaferon-LIPINT.
Terms and conditions of storage
According to the instructions, Grippferon is stored in a dry place at a temperature of 2-8 degrees Celsius. Regardless of the form of release, the shelf life of the drug is 2 years. After opening the bottle, the medicine should be used within 30 days.